Metraipolis › archive › dc_03644ca6fbe3
Risk prediction of severe chemotherapy-induced peripheral neuropathy in breast cancer patients receiving nab-paclitaxel: a clinical nomogram — Europe PMC PMID:42774478
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42774478
- DOI
- 10.3389/fphar.2026.1794696
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T00:10:00.020Z
- SHA-256 of the archived text
dab76bdcbddb9b122a210ec759a9cce27914a709b89270eaf16a06e0a6acf7c8- Stable URL of this page
https://metraipolis.com/documento/dc_03644ca6fbe3
How to cite
Risk prediction of severe chemotherapy-induced peripheral neuropathy in breast cancer patients receiving nab-paclitaxel: a clinical nomogram — Europe PMC PMID:42774478 — Europe PMC (en), https://europepmc.org/article/MED/42774478 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_03644ca6fbe3 (Metraipolis archive dc_03644ca6fbe3, sha256 dab76bdcbddb9b122a210ec759a9cce27914a709b89270eaf16a06e0a6acf7c8)
BibTeX
@misc{dc03644ca6fbe3,
title = {Risk prediction of severe chemotherapy-induced peripheral neuropathy in breast cancer patients receiving nab-paclitaxel: a clinical nomogram — Europe PMC PMID:42774478},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42774478},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_03644ca6fbe3; sha256 dab76bdcbddb9b122a210ec759a9cce27914a709b89270eaf16a06e0a6acf7c8},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42774478. Agents can read the archived copy with the MCP tool read_document.